SCHEMBL22148772

SCHEMBL22148772

c1ccc(-c2cc(-c3cccc(-c4c(-n5c6ccccc6c6ccccc65)c(-n5c6ccccc6c6ccccc65)nc(-n5c6ccccc6c6ccccc65)c4-n4c5ccccc5c5ccccc54)c3)cc(-c3ccccc3)n2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.35
MEN1 O00255 5/20 0.35
RAB9A P51151 1/20 0.35
ACHE P22303 1/20 0.34
CYP19A1 P11511 1/20 0.34
KDM4E B2RXH2 5/20 0.33
LMNA P02545 4/20 0.33
L3MBTL1 Q9Y468 3/20 0.33
ALDH1A1 P00352 3/20 0.33
TSHR P16473 2/20 0.33
MAPT P10636 2/20 0.33
ATM Q13315 1/20 0.33
NPC1 O15118 1/20 0.33
POLB P06746 1/20 0.33
GAA P10253 1/20 0.33
ALOX12 P18054 1/20 0.33
MAPK1 P28482 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
SMN1; SMN2 Q16637 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22148773 0.96 CYP19A1 (0.36) KMT2AMEN1RAB9AACHECYP19A1
SCHEMBL21889508 0.92 ACHE (0.37) KMT2AMEN1RAB9AACHECYP19A1
SCHEMBL22148511 0.91 CYP19A1 (0.38) KMT2AMEN1ACHECYP19A1KDM4E
SCHEMBL22148510 0.91 CYP19A1 (0.38) KMT2AMEN1ACHECYP19A1KDM4E
SCHEMBL30338985 0.90 TSPO (0.36) KMT2AMEN1ACHECYP19A1KDM4E
SCHEMBL30339202 0.90 TSPO (0.36) KMT2AMEN1ACHECYP19A1KDM4E
SCHEMBL22148774 0.90 MEN1 (0.42) KMT2AMEN1ACHEKDM4ELMNA
SCHEMBL21889491 0.89 CYP19A1 (0.39) KMT2AMEN1RAB9AACHECYP19A1
SCHEMBL22148533 0.88 MEN1 (0.42) KMT2AMEN1ACHEKDM4ELMNA
SCHEMBL23223066 0.86 CYP19A1 (0.36) KMT2AMEN1RAB9AACHECYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200203622-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200203622-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES NDUFV3, NDUFV2, CRY2 KMT2A 4367/4885MEN1 2193/4885RAB9A 3239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.